NGSベースRNAシーケンシングの世界市場 (2024～2028年)

NGSベースRNAシーケンシング市場 (2024～2028年)

NGSベースRNAシーケンシング市場は、2023年から2028年の間に20.52%のCAGRで成長し、66億5,900万米ドルにまで拡大すると予測されています。この調査レポートは、NGSベースRNAシーケンシング市場の全体的な分析、市場規模と予測、動向、成長促進要因・課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。この市場は、次世代シーケンシング手法の採用増加、シーケンシングプラットフォームの技術進歩、幅広い次世代シーケンシング製品の入手可能性などが牽引しています。

当レポートでは、次世代シーケンス技術の進歩が、今後数年間のNGSベースRNAシーケンシング市場の成長を促進する主な理由の1つであると特定しています。また、遺伝子シーケンスのコスト削減や、バイオインフォマティクスやクラウドベース・ソフトウェアプログラムの開発が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 (2023年)
• 市場の見通し (2023～2028年)

第4章 市場規模実績

• NGSベースRNAシーケンシングの世界市場 (2018～2022年)
• エンドユーザー別分析 (2018～2022年)
• 技術別分析 (2018～2022年)
• 地域別分析 (2018～2022年)
• 国別分析 (2018～2022年)

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 エンドユーザー別市場セグメンテーション

• 市場セグメンテーション
• 比較：エンドユーザー別
• 学術研究センター：市場規模と予測 (2023～2028年)
• 臨床研究：市場規模と予測 (2023～2028年)
• 製薬企業：市場規模と予測 (2023～2028年)
• 病院：市場規模と予測 (2023～2028年)
• エンドユーザー別の市場機会

第7章 技術別市場セグメンテーション

• 市場セグメンテーション
• 比較：技術別
• 合成による配列決定：市場規模と予測 (2023～2028年)
• イオン半導体シーケンシング：市場規模と予測 (2023～2028年)
• 単一分子リアルタイムシーケンシング：市場規模と予測 (2023～2028年)
• その他：市場規模と予測 (2023～2028年)
• 技術別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 (2023～2028年)
• 欧州：市場規模と予測 (2023～2028年)
• アジア：市場規模と予測 (2023～2028年)
• 世界のその他の地域：市場規模と予測 (2023～2028年)
• 米国：市場規模と予測 (2023～2028年)
• 英国：市場規模と予測 (2023～2028年)
• ドイツ：市場規模と予測 (2023～2028年)
• シンガポール：市場規模と予測 (2023～2028年)
• 中国：市場規模と予測 (2023～2028年)
• 地域別の市場機会

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Agilent Technologies Inc.
• Azenta Inc.
• BGI Genomics Co. Ltd.
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• Hamilton Co.
• Illumina Inc.
• Pacific Biosciences of California Inc.
• Perkin Elmer Inc.
• Psomagen Inc.
• QIAGEN NV
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Zymo Research Corp.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on End-user - Market share 2023-2028 (%)
• Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by End-user
• Exhibits35: Data Table on Comparison by End-user
• Exhibits36: Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
• Exhibits44: Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
• Exhibits45: Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
• Exhibits46: Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
• Exhibits47: Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
• Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits52: Market opportunity by End-user ($ million)
• Exhibits53: Data Table on Market opportunity by End-user ($ million)
• Exhibits54: Chart on Technology - Market share 2023-2028 (%)
• Exhibits55: Data Table on Technology - Market share 2023-2028 (%)
• Exhibits56: Chart on Comparison by Technology
• Exhibits57: Data Table on Comparison by Technology
• Exhibits58: Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
• Exhibits60: Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
• Exhibits61: Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
• Exhibits62: Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
• Exhibits64: Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
• Exhibits65: Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
• Exhibits66: Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
• Exhibits69: Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
• Exhibits70: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits73: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits74: Market opportunity by Technology ($ million)
• Exhibits75: Data Table on Market opportunity by Technology ($ million)
• Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits79: Chart on Geographic comparison
• Exhibits80: Data Table on Geographic comparison
• Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits102: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits103: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits109: Chart on Singapore - Market size and forecast 2023-2028 ($ million)
• Exhibits110: Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
• Exhibits111: Chart on Singapore - Year-over-year growth 2023-2028 (%)
• Exhibits112: Data Table on Singapore - Year-over-year growth 2023-2028 (%)
• Exhibits113: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits114: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits115: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits116: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits117: Market opportunity By Geographical Landscape ($ million)
• Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits119: Impact of drivers and challenges in 2023 and 2028
• Exhibits120: Overview on criticality of inputs and factors of differentiation
• Exhibits121: Overview on factors of disruption
• Exhibits122: Impact of key risks on business
• Exhibits123: Companies covered
• Exhibits124: Matrix on companies position and classification
• Exhibits125: Agilent Technologies Inc. - Overview
• Exhibits126: Agilent Technologies Inc. - Business segments
• Exhibits127: Agilent Technologies Inc. - Key news
• Exhibits128: Agilent Technologies Inc. - Key offerings
• Exhibits129: Agilent Technologies Inc. - Segment focus
• Exhibits130: Azenta Inc. - Overview
• Exhibits131: Azenta Inc. - Business segments
• Exhibits132: Azenta Inc. - Key news
• Exhibits133: Azenta Inc. - Key offerings
• Exhibits134: Azenta Inc. - Segment focus
• Exhibits135: BGI Genomics Co. Ltd. - Overview
• Exhibits136: BGI Genomics Co. Ltd. - Product / Service
• Exhibits137: BGI Genomics Co. Ltd. - Key offerings
• Exhibits138: Eurofins Scientific SE - Overview
• Exhibits139: Eurofins Scientific SE - Business segments
• Exhibits140: Eurofins Scientific SE - Key news
• Exhibits141: Eurofins Scientific SE - Key offerings
• Exhibits142: Eurofins Scientific SE - Segment focus
• Exhibits143: F. Hoffmann La Roche Ltd. - Overview
• Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits145: F. Hoffmann La Roche Ltd. - Key news
• Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits148: Hamilton Co. - Overview
• Exhibits149: Hamilton Co. - Product / Service
• Exhibits150: Hamilton Co. - Key offerings
• Exhibits151: Illumina Inc. - Overview
• Exhibits152: Illumina Inc. - Business segments
• Exhibits153: Illumina Inc. - Key news
• Exhibits154: Illumina Inc. - Key offerings
• Exhibits155: Illumina Inc. - Segment focus
• Exhibits156: Pacific Biosciences of California Inc. - Overview
• Exhibits157: Pacific Biosciences of California Inc. - Product / Service
• Exhibits158: Pacific Biosciences of California Inc. - Key offerings
• Exhibits159: Perkin Elmer Inc. - Overview
• Exhibits160: Perkin Elmer Inc. - Business segments
• Exhibits161: Perkin Elmer Inc. - Key news
• Exhibits162: Perkin Elmer Inc. - Key offerings
• Exhibits163: Perkin Elmer Inc. - Segment focus
• Exhibits164: Psomagen Inc. - Overview
• Exhibits165: Psomagen Inc. - Product / Service
• Exhibits166: Psomagen Inc. - Key offerings
• Exhibits167: QIAGEN NV - Overview
• Exhibits168: QIAGEN NV - Product / Service
• Exhibits169: QIAGEN NV - Key news
• Exhibits170: QIAGEN NV - Key offerings
• Exhibits171: Takara Bio Inc. - Overview
• Exhibits172: Takara Bio Inc. - Product / Service
• Exhibits173: Takara Bio Inc. - Key offerings
• Exhibits174: Tecan Trading AG - Overview
• Exhibits175: Tecan Trading AG - Business segments
• Exhibits176: Tecan Trading AG - Key news
• Exhibits177: Tecan Trading AG - Key offerings
• Exhibits178: Tecan Trading AG - Segment focus
• Exhibits179: Thermo Fisher Scientific Inc. - Overview
• Exhibits180: Thermo Fisher Scientific Inc. - Business segments
• Exhibits181: Thermo Fisher Scientific Inc. - Key news
• Exhibits182: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits183: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits184: Zymo Research Corp. - Overview
• Exhibits185: Zymo Research Corp. - Product / Service
• Exhibits186: Zymo Research Corp. - Key offerings
• Exhibits187: Inclusions checklist
• Exhibits188: Exclusions checklist
• Exhibits189: Currency conversion rates for US$
• Exhibits190: Research methodology
• Exhibits191: Information sources
• Exhibits192: Data validation
• Exhibits193: Validation techniques employed for market sizing
• Exhibits194: Data synthesis
• Exhibits195: 360 degree market analysis
• Exhibits196: List of abbreviations

NGS-based RNA-seq Market 2024-2028

The NGS-based RNA-seq market is forecasted to grow by USD 6659 mn during 2023-2028, accelerating at a CAGR of 20.52% during the forecast period. The report on the NGS-based RNA-seq market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased adoption of next generation sequencing methods, technological advancement in sequencing platforms, and availability of wide range of next generation sequencing products.

Technavio's NGS-based RNA-seq market is segmented as below:

By End-user

• Acamedic and research centers
• Clinical research
• Pharma companies
• Hospitals

By Technology

• Sequencing by synthesis
• Ion semiconductor sequencing
• Single-molecule real-time sequencing
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in next-generation sequencing techniques as one of the prime reasons driving the NGS-based RNA-seq market growth during the next few years. Also, reduced costs of gene sequencing and developments in the field of bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the NGS-based RNA-seq market covers the following areas:

• NGS-based RNA-seq market sizing
• NGS-based RNA-seq market forecast
• NGS-based RNA-seq market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading NGS-based RNA-seq market vendors that include Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., DNASTAR Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Hamilton Co., Illumina Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., PierianDx Inc., Precigen Inc., Psomagen Inc., QIAGEN NV, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Zymo Research Corp.. Also, the NGS-based RNA-seq market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global NGS-Based RNA-Seq Market 2018 - 2022
  • Historic Market Size - Data Table on Global NGS-Based RNA-Seq Market 2018 - 2022 ($ million)
• 4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Technology segment analysis 2018 - 2022
  • Historic Market Size - Technology Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 6.3 Acamedic and research centers - Market size and forecast 2023-2028
  • Chart on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Data Table on Acamedic and research centers - Market size and forecast 2023-2028 ($ million)
  • Chart on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
  • Data Table on Acamedic and research centers - Year-over-year growth 2023-2028 (%)
• 6.4 Clinical research - Market size and forecast 2023-2028
  • Chart on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Data Table on Clinical research - Market size and forecast 2023-2028 ($ million)
  • Chart on Clinical research - Year-over-year growth 2023-2028 (%)
  • Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
• 6.5 Pharma companies - Market size and forecast 2023-2028
  • Chart on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharma companies - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharma companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharma companies - Year-over-year growth 2023-2028 (%)
• 6.6 Hospitals - Market size and forecast 2023-2028
  • Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospitals - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technology

• 7.1 Market segments
  • Chart on Technology - Market share 2023-2028 (%)
  • Data Table on Technology - Market share 2023-2028 (%)
• 7.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
• 7.3 Sequencing by synthesis - Market size and forecast 2023-2028
  • Chart on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Data Table on Sequencing by synthesis - Market size and forecast 2023-2028 ($ million)
  • Chart on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
  • Data Table on Sequencing by synthesis - Year-over-year growth 2023-2028 (%)
• 7.4 Ion semiconductor sequencing - Market size and forecast 2023-2028
  • Chart on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ion semiconductor sequencing - Market size and forecast 2023-2028 ($ million)
  • Chart on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
  • Data Table on Ion semiconductor sequencing - Year-over-year growth 2023-2028 (%)
• 7.5 Single-molecule real-time sequencing - Market size and forecast 2023-2028
  • Chart on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Single-molecule real-time sequencing - Market size and forecast 2023-2028 ($ million)
  • Chart on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
  • Data Table on Single-molecule real-time sequencing - Year-over-year growth 2023-2028 (%)
• 7.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)
  • Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 Singapore - Market size and forecast 2023-2028
  • Chart on Singapore - Market size and forecast 2023-2028 ($ million)
  • Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
  • Chart on Singapore - Year-over-year growth 2023-2028 (%)
  • Data Table on Singapore - Year-over-year growth 2023-2028 (%)
• 9.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
• 12.4 Azenta Inc.
  • Azenta Inc. - Overview
  • Azenta Inc. - Business segments
  • Azenta Inc. - Key news
  • Azenta Inc. - Key offerings
  • Azenta Inc. - Segment focus
• 12.5 BGI Genomics Co. Ltd.
  • BGI Genomics Co. Ltd. - Overview
  • BGI Genomics Co. Ltd. - Product / Service
  • BGI Genomics Co. Ltd. - Key offerings
• 12.6 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key news
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
• 12.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Hamilton Co.
  • Hamilton Co. - Overview
  • Hamilton Co. - Product / Service
  • Hamilton Co. - Key offerings
• 12.9 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
• 12.10 Pacific Biosciences of California Inc.
  • Pacific Biosciences of California Inc. - Overview
  • Pacific Biosciences of California Inc. - Product / Service
  • Pacific Biosciences of California Inc. - Key offerings
• 12.11 Perkin Elmer Inc.
  • Perkin Elmer Inc. - Overview
  • Perkin Elmer Inc. - Business segments
  • Perkin Elmer Inc. - Key news
  • Perkin Elmer Inc. - Key offerings
  • Perkin Elmer Inc. - Segment focus
• 12.12 Psomagen Inc.
  • Psomagen Inc. - Overview
  • Psomagen Inc. - Product / Service
  • Psomagen Inc. - Key offerings
• 12.13 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
• 12.14 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key offerings
• 12.15 Tecan Trading AG
  • Tecan Trading AG - Overview
  • Tecan Trading AG - Business segments
  • Tecan Trading AG - Key news
  • Tecan Trading AG - Key offerings
  • Tecan Trading AG - Segment focus
• 12.16 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Zymo Research Corp.
  • Zymo Research Corp. - Overview
  • Zymo Research Corp. - Product / Service
  • Zymo Research Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations